Most bought healthcare stocks in Q2 2020
See which Healthcare stocks institutional investors increased the most in Q2 2020, measured as net growth in reported share positions from Q1 2020 into Q2 2020. Notable additions at the top of this list include CERUS CORP (CERS), ENVISTA HOLDINGS CORP (NVST), ABBVIE INC (ABBV), ZENTALIS PHARMACEUTICALS INC (ZNTL). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| CERS | CERUS CORP | 7,753,379 | $78.48M | 0 | 1 | 0 | 0 | 1 |
| NVST | ENVISTA HOLDINGS CORP | 7,171,637 | $173.33M | 1 | 1 | 1 | 0 | 3 |
| ABBV | ABBVIE INC | 5,869,879 | $898.47M | 4 | 5 | 6 | 0 | 16 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 4,443,284 | $213.37M | 1 | 0 | 0 | 0 | 1 |
| MCRB | SERES THERAPEUTICS INC | 4,148,123 | $31.32M | 0 | 2 | 0 | 0 | 2 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 4,038,433 | $15.63M | 0 | 1 | 0 | 0 | 2 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 3,348,094 | $89.70M | 0 | 1 | 0 | 0 | 1 |
| EXEL | EXELIXIS INC | 2,927,494 | $200.60M | 0 | 1 | 1 | 0 | 2 |
| ABT | ABBOTT LABORATORIES | 2,550,707 | $403.35M | 2 | 5 | 2 | 2 | 13 |
| HCA | HCA HEALTHCARE INC | 2,482,713 | $274.70M | 1 | 4 | 1 | 0 | 6 |
| EDIT | EDITAS MEDICINE INC | 2,010,226 | $119.42M | 0 | 1 | 2 | 0 | 3 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 1,908,750 | $78.95M | 1 | 4 | 2 | 1 | 8 |
| VCYT | VERACYTE INC | 1,797,934 | $51.76M | 0 | 1 | 0 | 0 | 1 |
| TMO | THERMO FISHER SCIENTIFIC INC | 1,683,851 | $745.90M | 1 | 3 | 6 | 1 | 12 |
| AMRN | AMARIN CORP PLC -ADR | 1,449,260 | $17.10M | 0 | 1 | 0 | 0 | 2 |
| INCY | INCYTE CORP | 1,438,115 | $428.26M | 0 | 3 | 1 | 1 | 4 |
| EHC | ENCOMPASS HEALTH CORP | 1,330,331 | $78.91M | 0 | 3 | 0 | 0 | 3 |
| EW | EDWARDS LIFESCIENCES CORP | 1,281,645 | -$165.69M | 1 | 7 | 0 | 3 | 8 |
| CLLS | CELLECTIS - ADR | 1,231,281 | $35.23M | 0 | 1 | 0 | 0 | 1 |
| INSM | INSMED INC | 1,227,400 | $33.80M | 1 | 0 | 0 | 0 | 1 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 1,211,314 | $38.05M | 0 | 1 | 1 | 0 | 2 |
| NTLA | INTELLIA THERAPEUTICS INC | 1,205,093 | $115.33M | 1 | 1 | 0 | 0 | 2 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 1,136,402 | $275.67M | 0 | 3 | 1 | 1 | 6 |
| LLY | ELI LILLY & CO | 1,082,816 | $100.97M | 1 | 3 | 4 | 1 | 8 |
| TWST | TWIST BIOSCIENCE CORP | 999,397 | $54.75M | 0 | 1 | 0 | 0 | 1 |
| PSNL | PERSONALIS INC | 964,618 | $17.92M | 0 | 1 | 0 | 0 | 1 |
| ZTS | ZOETIS INC | 930,962 | $444.27M | 3 | 3 | 3 | 1 | 9 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 854,237 | $203.04M | 2 | 1 | 0 | 0 | 3 |
| EXAS | EXACT SCIENCES CORP | 835,665 | $146.76M | 1 | 2 | 1 | 0 | 4 |
| XRAY | DENTSPLY SIRONA INC | 787,652 | $93.61M | 1 | 1 | 4 | 1 | 6 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 771,123 | $119.75M | 0 | 2 | 0 | 0 | 2 |
| DXCM | DEXCOM INC | 764,082 | $392.74M | 2 | 3 | 0 | 0 | 5 |
| MNKD | MANNKIND CORP | 762,715 | $1.33M | 1 | 0 | 0 | 0 | 1 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 690,600 | $21.60M | 0 | 1 | 0 | 0 | 1 |
| GMAB | GENMAB A/S -SP ADR | 666,012 | $37.42M | 0 | 1 | 2 | 0 | 3 |
| SYK | STRYKER CORP | 660,980 | $231.22M | 0 | 6 | 1 | 2 | 7 |
| TGTX | TG THERAPEUTICS INC | 643,600 | $17.47M | 0 | 1 | 0 | 0 | 1 |
| INVA | INNOVIVA INC | 632,894 | $30.94M | 0 | 2 | 0 | 0 | 2 |
| CORT | CORCEPT THERAPEUTICS INC | 617,155 | $51.31M | 0 | 1 | 0 | 0 | 1 |
| TXG | 10X GENOMICS INC-CLASS A | 615,653 | $55.27M | 1 | 1 | 0 | 0 | 2 |
| HALO | HALOZYME THERAPEUTICS INC | 613,753 | $33.73M | 0 | 1 | 2 | 0 | 3 |
| REGN | REGENERON PHARMACEUTICALS | 573,675 | $662.66M | 3 | 3 | 1 | 2 | 7 |
| SRPT | SAREPTA THERAPEUTICS INC | 554,282 | $94.94M | 1 | 2 | 0 | 0 | 3 |
| PDCO | PATTERSON COS INC | 532,108 | $17.07M | 0 | 1 | 2 | 0 | 3 |
| CDNA | CAREDX INC | 487,358 | $27.99M | 0 | 1 | 0 | 0 | 1 |
| CLDX | CELLDEX THERAPEUTICS INC | 466,988 | $19.34M | 0 | 1 | 0 | 0 | 1 |
| FATE | FATE THERAPEUTICS INC | 464,748 | $22.66M | 0 | 1 | 0 | 0 | 1 |
| BDX | BECTON DICKINSON AND CO | 449,918 | $207.61M | 1 | 7 | 4 | 2 | 12 |
| HSIC | HENRY SCHEIN INC | 435,559 | $37.16M | 1 | 3 | 1 | 0 | 5 |
| CLSD | CLEARSIDE BIOMEDICAL INC | 418,550 | $858.00K | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q2 2020
What are the most bought Healthcare stocks in Q2 2020?
The most bought healthcare stocks in Q2 2020 are those with the largest increase in reported share counts across institutional investors compared to Q1 2020, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2020?
Among filers in this sector, net additions were largest in companies such as CERUS CORP (CERS), ENVISTA HOLDINGS CORP (NVST), ABBVIE INC (ABBV), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2020).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.